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Painful stimuli arising within visceral organs are detected by peripheral nerve 
endings of spinal afferents, whose cell bodies are located in dorsal root ganglia 
(DRG). Recent technical advances have made it possible to reliably expose and 
inject single DRG with neuronal tracers or viruses in vivo. This has facilitated, for the 
first time, unequivocal identification of different types of spinal afferent endings in 
visceral organs. These technical advances paved the way for a very exciting series 
of in vivo experiments where individual DRG are injected to facilitate opsin 
expression (e.g. Archaerodopsin). Organ-specific expression of opsins in sensory 
neurons may be achieved by retrograde viral transduction. This means activity of 
target-specific populations of sensory neurons, within single DRG, can be modulated 
by optogenetic photo-stimulation. Using this approach we implanted micro light-
emitting diodes (micro-LEDs) adjacent to DRG of interest, thereby allowing focal 
DRG-specific control of visceral and/or somatic afferents in conscious mice. This is 
vastly different from broad photo-illumination of peripheral nerve endings, which are 
dispersed over much larger surface areas across an entire visceral organ; and 
embedded deep within multiple anatomical layers. Focal DRG photo-stimulation also 
avoids the potential that wide-field illumination of the periphery could inadvertently 
activate other closely apposed organs, or co-activate different classes of axons in 
the same organ (e.g. enteric and spinal afferent endings in the gut). It is now 
possible to selectively control nociceptive and/or non-nociceptive pathways to 
specific visceral organs in vivo, using wireless optogenetics and micro-LEDs 
implanted adjacent to DRG, for targeted photo-stimulation.   
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Pain is an evolutionary adaptation to avoid potential or actual tissue damaging events (Smith 
and Lewin, 2009). Painful sensations are initiated by specific classes of sensory neurons that 
can discriminate noxious stimuli, from physiologically-innocuous stimuli. Sensory neurons that 
can respond to noxious stimuli are called nociceptors (Perl, 2007). Compared to somatic pain, 
visceral pain is typically a diffuse and poorly localized sensation (Cervero and Laird, 1999) and 
the mechanisms underlying transduction of visceral pain are poorly understood (Gebhart and 
Bielefeldt, 2016). Indeed, the different morphological types of somatic nociceptor endings have 
been well characterized, particularly in skin (Mense, 2009). In contrast, the distribution and 
morphologies of the sensory nerve endings that underlie detection of visceral pain remains 
mysterious. Recently, major technical developments have allowed unequivocal identification of 
the spinal afferent nerve endings that underlie murine visceral sensation to be characterized 
(Kyloh and Spencer, 2014, Spencer et al., 2016c). This technique has also allowed a major 
new series of experiments to be undertaken using wireless optogenetics to control visceral 
sensations. These advances will be discussed below. 
 
Sensory pathways innervating visceral organs  
In vertebrates, two major sensory pathways innervate the body, below the head. These are the 
vagal and spinal afferents, which provide the vast majority of sensory innervation to visceral 
and somatic organs (Gebhart and Bielefeldt, 2016). These two sensory pathways have distinct 
origins and encode different stimuli (Powley et al., 2005, Powley et al., 2015, Brierley et al., 
2004). The nerve cell bodies of vagal afferents arise from nodose and jugular ganglia, while 
spinal afferents arise from DRG (Gebhart and Bielefeldt, 2016). While some evidence 
suggests that the vagus nerve can respond to nociceptive stimuli (Yu et al., 2005), there is a 
long held belief that vagal afferents play little, or no role, in the transmission of visceral pain 
sensations that arise from internal organs (Gebhart and Bielefeldt, 2016). Indeed, there is no 
doubt that the vast majority, if not all visceral pain is transmitted via spinal afferents, whose 
sensory pathways enter the dorsal horn of the spinal cord (Gebhart and Bielefeldt, 2016). This 
is supported by selective lesions to particular spinal afferent pathways which abolishes 
noxious responses from visceral organs, like the large intestine (Kyloh et al., 2011). For this 
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reason, spinal afferents are of supreme interest to understand the mechanisms of visceral 
nociception (Gebhart and Bielefeldt, 2016).  
 
Overcoming technical obstacles to identify spinal afferent endings 
The major obstacles to identification of visceral spinal afferent nerve endings has been their 
positive discrimination from other sensory and motor nerve axons, which travel along the same 
mixed nerve trunks. Disentangling afferent from efferent axons and their nerve endings within 
visceral organs has been exceptionally challenging. In the gastrointestinal tract, identifying 
spinal afferents has been even more challenging than in other visceral organs, because the 
gut’s own independent nervous system (Furness, 2006b, Furness, 2006a), the enteric nervous 
system, contains many neurochemical markers also expressed in DRG neurons. These 
include neuropeptides such as Calcitonin Gene Related Peptide (CGRP) and substance P 
(Costa et al., 1996).  
 
Unlike spinal afferents, whose endings have only recently been identified with selective tracing 
methods, the terminals of vagal afferent neurons have been well described in viscera (Powley, 
2000, Powley et al., 2013, Powley and Phillips, 2011). This is largely due to the comparative 
ease of accessing the nodose ganglia using surgical approaches (Powley, 2000, Powley et al., 
2013, Powley and Phillips, 2011). Injection of neuronal tracers into the nodose ganglia enables 
selective unambiguous anterograde labelling of vagal afferent nerve terminals (Powley, 2000, 
Powley et al., 2013). 
 
Development of anterograde tracing to selectively label spinal afferents in visceral 
organs and their nerve endings 
The recent technical development of selective anterograde tracing from DRG has enabled 
selective labeling of spinal afferent axons and endings (Spencer et al., 2014, Spencer et al., 
2016a). Using this technique, numerous spinal afferent endings, most of which had never been 
previously unidentified, were labelled in the large intestine (Spencer et al., 2014), stomach and 
esophagus (Spencer et al., 2016a), and urinary bladder (Spencer et al., 2018). Some, or all of 
the different types of endings identified must contribute to the sensation of pain, because 
lesions to spinal afferent pathways abolishes pain transmission from organs like the gut (Kyloh 
et al., 2011). Exposing DRG as a survival surgery in mice is now routine in our laboratory and 
has revealed significant new information on the morphology, neurochemical coding and sites 
of innervation of spinal afferents (Spencer et al., 2016c). One of the major benefits of this 
technique is that reducing quantities of injected tracer to very small amounts often results in 
labelling of single spinal afferent axons and their associated endings. This enables 
visualization of single afferent nerves, without contamination by other axons in the field of view 
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(Spencer et al., 2014, Spencer et al., 2016a). This enabled the first unequivocal correlation of 
the outputs (endings) arising from a single spinal afferent axon in viscera (Fig.1). 
 
Use of transgenic reporter mice – can they identify spinal afferent nerve endings? 
Recently, we generated a transgenic mouse in which the fluorescent reporter mCherry was 
knocked into the CGRPα locus (Hibberd et al., 2016). This had also been performed using 
different reporter genes by earlier investigators (McCoy et al., 2012). CGRPα is highly 
expressed in DRG neurons, making it particularly a useful marker (Mulderry et al., 1988). This 
mouse has proved very useful for the visualization of peptidergic spinal afferent neurons in live 
DRG and visceral organs (Hibberd et al., 2016). However, the morphological resolution of 
CGRPα expressing axons was low in visceral organs and precise morphological features of 
spinal afferents could not be determined (Spencer et al., 2016b). Nevertheless, the reporter 
(mCherry) signal enabled recordings from individual varicosities of spinal afferent axon 
terminals within live visceral organs, such as the gut wall) (Spencer et al., 2016b), and was 
also useful in reporting the functional properties of the peptidergic and non-peptidergic sensory 
nerve cell bodies in live tissue (Hibberd et al., 2016). 
 
Optogenetic control of spinal afferent pathways  
Recent studies have demonstrated the effectiveness of optogenetics in the selective activation 
of specific classes of visceral afferents in vitro (Feng et al., 2016). These studies showed that 
different functional classes of spinal afferents from the mouse large intestine can be identified 
by applying focal pulses of blue light to isolated segments of distal colon in vitro (Feng et al., 
2016).  
 
A challenge for optogenetic illumination of visceral organs in vivo has been how to selectively 
control light penetration to deep visceral organs without spread to neighboring organs. Our 
experience has led us to believe that there are significant advantages for optogenetic control 
of visceral organs if light is delivered to visceral sensory neurons at the DRG rather than at the 
peripheral nerve endings within the organ. We have been working to develop wirelessly-
activated micro-LEDs with appropriate dimensions to deliver blue or green pulses of light 
directly onto DRG sensory nerve cell bodies to control visceral sensation in conscious 
mammals. To do this, the micro-LEDs were developed with specific dimensions to implant 
adjacent to DRG during survival surgery (Fig.2). There are multiple advantages of implanting 
micro-LEDs adjacent to DRG. Firstly, the sensory nerve cell bodies are concentrated into a 
~1mm diameter region of tissue (in mice), where deep penetration of light is not required. This 
contrasts with their peripheral nerve endings which are located long distances away from 
nerve cell bodies innervate much larger spatial fields. Secondly, DRG consist only of spinal 
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afferent neurons and lack synaptic inputs. Therefore, since no other classes of sensory or 
motor nerve axons arise from DRG, or provide en passant innervation to DRG, this means 
direct illumination of DRG with micro-LEDs provides selective control of spinal afferent 
neurons. This contrasts with light delivery in peripheral visceral organs, where multiple 
functional classes of axons can express the same genes and may cause inadvertent co-
activation. The gut wall for example, contains both spinal afferent nerve endings (Mulderry et 
al., 1988, Hibberd et al., 2016) and enteric neurons that express CGRP (Furness et al., 2004). 
Therefore, photostimulation of the gut wall could indiscriminately activate spinal afferents and 
enteric nerves (Mulderry et al., 1988, Hibberd et al., 2016). Also, delivering light to any 
periphery organ would require illumination of a larger spatial field compared with individual 
DRGs, which in mice are approximately 1mm in diameter. Finally, when illuminating light to 
any peripheral organ, it can be problematic preventing dispersed light from inadvertently 
activating other neighboring organs (if they also express the opsins). For these reasons, we 
felt direct illumination of DRG sensory nerve cell bodies with micro-LEDs represents a number 
of conspicuous advantages in terms of targeting pure visceral sensory pathways.  
 
We have recently implanted single or multiple micro-LEDs (green or blue) adjacent to DRGs of 
interest, with no cases of infection or rejection by the animal. We have demonstrated in pilot 
experiments that at least 4 miniature micro-LEDs can be activated simultaneously, via wireless 
technology (Fig.2). Prior to implantation of the micro-LEDs, single DRGs are injected with cre-
inducible adeno-associated viruses that lead to opsin expression. In transgenic TRPV1-cre 
mice, it was found that after 4-5 weeks post DRG viral injection of a cre-inducible AAV (AAV5-
EF1a-DIO-hCHR2(H134R)-eYFP) into single DRG, robust expression of yellow fluorescent 
protein (YFP) developed in numerous TRPV1-immunoreactive, cre-expressing sensory 
neurons (Fig.3). This approach of injecting AAVs directly into DRGs is an alternative strategy 
for generating expression of opsins in DRG neurons exclusively. 
 
Evidence for optogenetic control of visceral sensation  
Although wireless optogenetics has been convincingly demonstrated to control somatic 
sensation and behaviour (Montgomery et al., 2015), only recently, has this technology been 
used to effectively control visceral sensation (Samineni et al., 2017). This recent work has 
shown that in transgenic mice expressing the light-activated inhibitory proton pump, 
Archaerhodopsin (under the control of the sensory-neuron specific sodium channel (sns) 
promoter), photo-stimulation effectively silenced bladder afferents underlying the visceromotor 
response in vivo (Samineni et al., 2017). This is sound evidence that visceral pain pathways 
can be effectively silenced using wireless photo-stimulation of Archaerhodopsin. 
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Optogenetic control of spinal afferent pathways to specific organs in conscious  
non-transgenic animals 
Of particular interest to our laboratory is selective, visceral organ-specific control of nociceptive 
and non-nociceptive pathways in non-transgenic animals. This has been successfully 
demonstrated for somatic nociception in non-transgenic mice (Iyer et al., 2014) and rats 
(Boada et al., 2014). In the study by Iyer et al. (2014), the adeno-associated virus AAV6-hSyn-
eNpHR3.0-eYFP was injected into the sciatic nerve, which was found to retrogradely transport 
successfully to DRG, leading to sufficient expression of halorhodopsin in sensory neurons. 
These investigators then showed that transdermal yellow light applied to the hind-limb reduced 
acute pain perception, reversed mechanical allodynia and reversed thermal hyperalgesia in a 
neuropathic pain model (Iyer et al., 2014). These experiments were possible because light was 
delivered transdermally (to an external organ), so that pain responses could be induced in 
freely moving animals. However, delivering light focally, to specific internal organs, in 
conscious, freely-moving, untethered animals is more difficult. To get around this, micro-LEDs 
can be implanted and fixed adjacent to DRG in non-transgenic animals (Fig.3A) after injection 
of AAVs in visceral organ(s) of interest. In this scenario, target-specific visceral afferents can 
be controlled directly at the DRG level, without illuminating the organ itself. In another study, 
transgenic mice expressing Archerodopsin under the control of the Nav1.8 promoter, it was 
found that acute transdermal illumination of the hind paws led to a clear reduction in allodynia 
to mechanical stimuli under inflammatory conditions (Daou et al., 2016). The study also 
showed that basal mechanical sensitivity was not affected by the illumination (Daou et al., 
2016). 
 
Another possibility for wireless optogenetic control of DRG in non-transgenic animals is to use 
two different viruses to express opsins in DRG. This can be performed by first injecting the 
canine adenovirus-2 (Cav-2) into the target organ of interest (e.g. gut) (Fig.2) which transports 
readily retrograde along axons (Junyent and Kremer, 2015). Then, a cre-inducible AAV is 
injected into the DRG of interest, such that only the sensory neurons that project to the target 
organ will express the opsins. Implantation of micro-LEDs at the DRG could then be used to 
selectively control visceral afferent pathways to specific organs in vivo, in non-transgenic 
animals.  
 
Advantages of wireless optogenetic photo-illumination of DRG to selectively control 
visceral afferent pathways in conscious animals 
 Specific populations of sensory neurons projecting to particular visceral organs (e.g. 
GI-tract or bladder) can be selectively activated, or silenced at particular DRG levels of 
interest.  
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 Selective activation or silencing of individual DRGs can be used to determine the 
functional contribution of each vertebral segment to nociceptive responses.  
 Direct photo-stimulation of DRG can only activate spinal afferents - since no other 
classes of sensory or motor nerve cell bodies (or axons) reside in, or pass through 
DRG. This avoids the potential concern arising with illumination of the mixed neural 
innervation of peripheral organs, where concomitant activation of other functional 
classes of sensory or motor axons can occur. 
 Direct DRG photo-stimulation is highly focused (~1mm2) and avoids the need for broad 
illumination of large surface areas in peripheral target organs. This also reduces 
potential for inadvertent non-specific illumination of neighboring organs.  
 Multiple micro-LEDs can be wirelessly activated at the same time at different DRG 
levels (Fig.2).  
 DRG photo-stimulation enables direct modulation of spinal afferent cell bodies, 
requiring a shallow depth of photo-penetration (~100-200µm). Achieving full activation 
of all populations of spinal nerve endings throughout the full depth of peripheral organs 
in viscera requires considerably deeper photo-penetration. [Spinal afferent endings 
have been shown to have varying depths of innervation in viscera, commonly 1-2mm 
deep in gut or bladder]. 
 Spinal afferent pathways to specific visceral organs could be readily activated or 
silenced in non-transgenic animals, using the described technique of direct DRG 
illumination. 
 
Disadvantages of wireless optogenetic photo-illumination of DRG to selectively control 
visceral afferent pathways in conscious animals 
 It requires surgery to implant the micro-LEDs.  
 There is always possibility of rejection or infection with implanting foreign bodies in 
vivo.  
 Multiple micro-LEDs would be required to be implanted at multiple vertebral segments 
to completely silence visceral pain pathways, which are known to enter the spinal cord 
at multiple vertebral segments.  
 
Differences between chemogenetics and optogenetics for control of visceral 
nociception 
There is gathering interest in the use of designer receptors exclusively activated by designer 
drugs (DREADDs) to control sensory pathways (including those of nociceptive origin) in 
genetically defined cell populations, both in vitro and in vivo. Both excitatory G-protein (Gq)-
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DREADD (hM3Dq) and the inhibitory G-protein (Gi)-DREADD (hM4Di) exist which are under 
exclusive control of the biologically inert compound clozapine N-oxide (CNO). There are some 
significances in the mechanisms of DREADD technology to study visceral pain compared with 
optogenetics. For example, DREADDs are advantageous for studying phenotypes of neurons 
that are diffusely scattered in multiple organs. Therefore, CNO application penetrates a wider 
area than can be achieved with optogenetics, where neurons only in the immediate arc of light 
are activated. Unlike optogenetics, which allows fast and reversible control of neuron activity, 
manipulation of hM3Dq and hM4Di receptors affects neuronal activity over many minutes to 
hours. A recent study has demonstrated that Gi-DREADD expression in peripheral nerves can 
produce a ligand-dependent analgesia to heat in vivo and also reduced neuronal firing in 
single-cells in vitro (Saloman et al., 2016). Interestingly, however, the authors revealed that 
expression of Gi-DREADD also caused ligand-independent changes in ion channel activity 




The recent development that single DRG in mice can now be reliably exposed and injected 
with viruses, or neuronal tracers as a survival surgery, is a major step forward in our ability to 
visualize and selectively control spinal afferent pathways to specific visceral organs. This 
advance means that we can not only identify the location and morphology of spinal afferent 
endings, but we can selectively express opsins in particular classes of neurons in specific 
DRGs. The advantage of exposing single DRGs has the major benefit of being able to implant 
micro-LEDs adjacent neuronal cell bodies facilitating direct wireless activation or inhibition of 
visceral or somatic afferent pathways. The micro-LEDs we developed have specific 
dimensions compatible with implantation adjacent to single DRG in mice and can be modified 
readily for rats. 
 
There is no doubt there is a desperate need for alternative techniques to suppress chronic 
pain. In this regard, there is significant interest in the pursuit of alternative techniques to 
suppress nociception, without drugs. Wireless optogenetic illumination of specific populations 
of sensory nerve cell bodies in DRG is an exciting reality for selective control of visceral pain 
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Novel technique to selectively label spinal afferent axons and nerve endings in visceral organs. 
During anesthesia, a midline incision is made in the dorsal surface to expose relevant DRG. A 
glass micropipette filled with dextran biotin is injected into single DRG of interest. Because 
DRG contain only the sensory neurons of spinal afferents, this means that only spinal afferent 
axons and endings will be selectively labeled in the target visceral organs. A major advantage 
of this technique is that it simultaneously labels spinal afferents in the urinary bladder, colon 
and uterus, when injections are made into the lumbosacral DRGs. B, shows a single spinal 
afferent axon and diverse morphological types of endings in the detrusor muscle of the mouse 
urinary bladder. C, shows a complex-type spinal afferent ending in the urinary bladder. D, 
shows a single spinal afferent axon in the detrusor muscle branching into multiple complex-
type endings.  
 
Figure 2. 
 Development of wireless optogenetics for control of visceral pain. A, resonant cavity with 
micro blue LED activated. B, green LED for activation of Archaerhodopsin in DRG sensory 
neurons. C, micro LED and receiver, built in house. The relative size of the micro LED is 
shown adjacent to a match head. D, demonstration that multiple blue and green micro LEDs 
can be activated simultaneously via wireless resonant cavity. E, circuit board of wireless micro 
LED. F, Diagrammatic representation of the technique to suppress nociception selectively from 
target visceral organs. Firstly, cre-inducible AAV in a double-floxed inverted orientation 
expressing Channelrhodopsin and yellow fluorescent protein (e-YFP) is injected into single 
DRG at relevant vertebral level. Then a cre-inducible AAV is injected into the target organ of 
interest. This facilitates retrograde transport of cre back into only the DRG sensory neurons 
that project to the colon. Therefore, this means that Archaerhodopsin or Channelrhopsin will 
be expressed in only colon-projecting sensory neurons. Therefore, when green or blue LEDs 
are illuminated onto DRGs at the relevant location, this means that colon-projecting sensory 
neurons can be selectively activated or inhibited.    
 
Figure 3.  
Technique to implant wireless micro-LEDs adjacent to DRGs for silencing visceral pain. A, 
cartoon representing the site of implanting micro LEDs adjacent to DRGs in the lumbosacral 
region of spinal cord to control visceral nociception to the lower gastrointestinal tract. Blue or 
green LEDs surgically implanted adjacent to DRGs can be used to wirelessly activate or inhibit 
colon-projecting sensory neurons of selectively. B, in a TRPV1-cre mouse line (Lagerstrom et 
al., 2010), injection of AAV5-DIO-Arch 3.0-eYFP generates yellow fluorescent protein 
expression in TRPV1+ve sensory neurons. Image shows a whole mounted TRPV1-Cre 
positive DRG (left L6 and S1) injected with rAAV5/EF1a-DIO-eArch3.0-eYFP to induce 
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expression of Archaerhodopsin. B, shows TRPV1 immunoreactivity from L6 and S1 DRG, C, 
show the same image in B with YFP expression 5 weeks after injection of 50nL of active 
rAAV5/EF1a-DIO-eArch3.0-eYFP into L6 and S1 DRG. D, show co-localization of both YFP 
and TRPV1 expression from B and C, respectively. Red arrows indicate areas of co-
localisation. Scale bar, 100µm. 
  
  




 Recent studies have now demonstrated that anterograde tracing can be reliably 
performed from dorsal root ganglia (DRG) in vivo, to identify single spinal axons and 
their associated nerve endings, in visceral organs. 
 Channelrhodopsin or Archaerhodopsin can now be selectively expressed in single 
DRG, following viral injections into single DRG in vivo. 
 Wireless micro-light emitting diodes (micro-LEDs) can now be implanted adjacent to 
single DRG in live mice. 
 Visceral sensation, including nociceptive and non-nociceptive pathways, can now be 
selectively controlled to specific target organs, by wireless optogenetics, via photo-
stimulation at the level of single DRGs. 
 There are a number of significant advantages of photo-stimulation at the DRG level in 
vivo for wireless optogenetic control of visceral and/or somatic sensation, compared 
with broad photo-stimulation of large surface areas of peripheral organs.   
 
 
